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Currently, there are no tools to predict postsurgery outcome after kidney
transplantation. This study assesses whether frailty influence 30-day post-
operative complications after kidney transplantation. One-hundred and
fifty kidney transplantations were prospectively included. Frailty was
assessed using a frailty indicator, consisting of 15 questions, covering most
domains of functioning. Postoperative complications were measured by the
Comprehensive Complication Index (CCI). Using a linear regression
model, 30-day postoperative complications and frailty correlation were
adjusted for confounders, including sex, age, ASA Score, Charlson Comor-
bidity Index, hypertension, BMI, smoking, dialysis, duration of dialysis,
type of transplantation, and retransplantation. The mean frailty score was
2.07(1.6) and 23 patients were classified as frail (GFI ≥4). The mean
CCI-score was 18(15.6), the mean CCI-score for “frail” patients 30.1
(17.2) compared to 15.5 (14.2) for “non-frail” patients (N = 116). In a
regression analysis, a significant relationship between CCI-score and frailty
(b = 13.3; 95% CI 5.7–20.9; P = 0.0007) and transplantation type
(b = 4.9; 95% CI: 0.72–9.16; P = 0.02) was found, independent of con-
founders. In conclusion, frailty and type of transplantation are independent
factors associated with an increased risk of postoperative complications.
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Introduction
Currently, there is a lack of reliable tools that can help
to predict 30-day outcome after a kidney transplanta-
tion. Even models that are based on relatively large
databases have poor predictive values of 67% and 64%
for 1- and 3-year adult graft survival, respectively [1].
This means that there is no risk prediction tool avail-
able that is materially better than a risk prediction by
chance.
Recently, frailty has emerged as a significant risk fac-
tor for adverse postoperative outcomes. Frailty is the
clinically recognizable medical condition, also called
syndrome or phenotype, that is, the result of processes
leading to an increased vulnerability for serious deterio-
rations in health and the diminished ability to cope
with physical stressors. It is related to declines in
energy, strength, and function as well as to an increased
inflammatory state, including elevated levels of inter-
leukin 6 (IL-6), C-reactive protein (CRP), and an
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elevated white blood cell count [2–4]. Frailty, as defined
in the landmark paper by Fried [2], included at least
three of five of the following criteria: unintentional loss
of weight, low physical activity, low energy, low grip
strength, and a slowed walking speed. Since then, vari-
ous frailty scoring lists have been designed to optimize
the predictive value. One of these is the Groningen
Frailty Indicator (GFI), an instrument that includes
aspects that have not been covered by previous meth-
ods, proved independent of age and comprises both a
professional and a self-assessed version [5,6]. Further-
more, the GFI can be assessed quickly, using only a
simple questionnaire which usually does not require
more than five minutes to be completed and which cov-
ers most domains of functioning, making it easy and
fast to get a reliable impression of the degree of frailty.
Frailty has previously been proven to be an independent
predictor for adverse outcome after major surgery in
which frail patients had 2.5 times higher odds for post-
operative complications within 30 days after surgery
[7].
Additionally, the GFI proved to have a positive pre-
dictive value for postoperative delirium after vascular
surgery [8].
The aim of this study was to determine which factors,
with emphasis on frailty, significantly influence postop-
erative outcome after kidney transplantation as mea-
sured by the Comprehensive Complication Index (CCI)
[9].
Patients and methods
Study design and participants
From January 2015 to October 2016, 150 consecutive
living and deceased kidney transplant recipients were
prospectively included at the University Medical Cen-
ter Groningen, the Netherlands (UMCG). Eleven
patients were excluded for reasons such as combined
kidney–pancreas transplantation or procedures that
got cancelled due to insufficient health of the donor
or recipient, allowing 139 patients to be included for
the final analysis in the study. Every patient that
agreed on measuring the GFI and that did not get
excluded for one of the previously mentioned reasons
got subsequently included.
Follow-up, clinical and laboratory data were prospec-
tively collected and complemented by reviewing the dig-
ital medical records. For this study, the Medical Ethical
Committee granted dispensation for the Dutch law
regarding patient-based medical research (WMO)
obligation (registration no METc2017/070). Patient data
were anonymously processed and electronically stored.
All procedures were conducted in accordance with the
Declarations of Helsinki and Istanbul.
Frailty
At admission, frailty was assessed by a nurse or doctor
not involved in this study for each patient using the
GFI [6] (Table 1). The GFI is classified in eight separate
groups of in total 15 questions that are consistent with
the domains of functioning: mobility, visual function-
ing, auditory functioning, nutritional status, comorbid-
ity, cognition, psychosocial aspects and fitness, resulting
in a minimal score of 0 and a maximal score of 15.
Based on previous publications, frailty was defined as a
GFI score ≥4 [6,8,10].
Complications
Postoperative complications were registered and ana-
lyzed using the CCI, which is a tool that summarizes all
postoperative complications with respect to their sever-
ity according to the Clavien–Dindo classification of sur-
gical complications, consisting of five complication
grades including four subgrades [9]. In short, grade one
consists of any deviation from the normal postoperative
course, without the need of surgical, endoscopic, radio-
logical, or pharmacological treatment besides antiemet-
ics, antipyretics, analgetics, diuretics, and electrolytes,
and physical therapy. The second grade includes all
other pharmacological treatments, blood transfusions,
and parenteral nutrition. Third grade complications
require surgical, endoscopic, or radiological treatment.
Grade four includes life-threatening complications
requiring intensive care unit (ICU) management,
whereas grade five concerns the death of the patient.
The CCI takes the quantity of appearance of each com-
plication into account, using a specific calculation that
yields a score from 0 to 100, thereby giving a very
detailed assessment for every patient. The kidney trans-
plantation procedure, as performed at our hospital, has
been published previously by our group [11]. Our pri-
mary outcome measure was 30-day postoperative com-
plications according to the CCI.
Clinical data selection
Collected data included age (years), sex, American Soci-
ety of Anesthesiologists physical status classification sys-
tem (ASA) score, hypertension, body mass index (BMI),
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smoking (y/n), dialysis (y/n), duration of dialysis
(months), type of transplantation (living or deceased),
and retransplantation (y/n). Comorbidity was deter-
mined by the age-adjusted Charlson Comorbidity Index,
based on the previous medical history. The Charlson
Comorbidity Index is a widely used method for predict-
ing mortality. It is composed from a total of 22 differ-
ently weighted comorbidities (myocardial infarct,
congestive heart failure, peripheral vascular disease,
dementia, cerebrovascular disease, chronic lung
disease, connective tissue disease, ulcer, chronic liver
disease, diabetes, hemiplegia, moderate or severe kidney
disease, diabetes with end organ damage, tumor, leuke-
mia, lymphoma, moderate or severe liver disease, malig-
nant tumor, metastasis, AIDS) which can be adjusted
for age and results in a prediction of the 1-year mortal-
ity and is widely used [12].
Statistical analysis
Summary statistics were obtained using conventional
methods, normally distributed data are expressed as
mean and standard deviation (SD) and skewed data as
medians and interquartile range (IQR). Frequencies and
proportions are reported for categorical data.
The analyses of the effect of GFI on 30-day outcome
as measured by the CCI were adjusted for potentially
important confounders (sex, age (years), ASA score,
Charlson Comorbidity Index, hypertension, body mass
index (BMI), smoking (y/n), dialysis (y/n), duration of
dialysis (months), type of transplantation (living or
deceased), and retransplantation) by using a preselec-
tion, that is, starting with a univariate analysis of all
mentioned variables with the 30-day CCI as dependent
variable and then using the most significant variables
Table 1. The Groningen Frailty Indicator (GFI).
Yes No
Mobility
Can the patient perform this task without any help? (using tools like walking sticks, wheelchairs or walker is regarded as
independent)
1. Go shopping 0 1
2. Walk around outside (around the house or to neighbors) 0 1
3. Dressing and undressing 0 1
4. Toilet visit 0 1
Vision
5. Does the patient experience problems in daily life by poor vision? 1 0
Hearing
6. Does the patient experience problems in daily life by poor hearing? 1 0
Nutrition
7. Has the patient involuntarily lost weight (≥6 kg) in the past 6 months
(or ≥3 kg in 1 month)
1 0
Comorbidity
8. Does the patient currently use four or more different types of medication? 1 0
Yes No Sometimes
Cognition
9. Does the patient currently has complaints about his memory (or has a history of dementia) 1 0 0
Psychosocial
10. Does the patient sometimes experience emptiness around him? 1 0 1
11. Does the patient sometimes miss people around him? 1 0 1
12. Does the patient sometimes feel abandoned? 1 0 1
13. Has the patient recently felt sad or depressed? 1 0 1
14. Has the patient recently felt nervous or anxious? 1 0 1
Physical fitness
15. Which grade would the patient give its physical fitness
(0–10, ranging from very bad to good) 0–6 = 1 7–10 = 0
1 0
Total score GFI
A score of four or more indicates a higher risk for frailty.
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with a P-value <0.2 for the multivariable analysis in-
cluding all remaining variables. Variables that were
known to affect both frailty and complications (duration
of dialysis and retransplantation) were, independent of
statistical significance, added to the adjusted model. Due
to its overlap with the Charlson Comorbidity Index and
in order not to overfit the model, we excluded the ASA
score out of the adjusted model [13,14]. Estimates of the
effects were reported with corresponding 95% confi-
dence intervals. A linear regression was carried out using
the Statistical Package for the Social Sciences (Released
2015. IBM SPSS Statistics for Windows, Version 23.0.
IBM Corp., Armonk, NY, USA).
Results
Baseline characteristics
Baseline characteristics are presented in Table 2. Mean
age was 51.8 (14.5 SD) years (18–81) and 62.9% were
male. Mean age for males was 52.7 (14.6) years and
50.4 (14.3) years for women. Mean age for frail
patients was 50.1 years and 52.2 for nonfrail patients.
Mean BMI was 26 (4.5) kg/m2. Eighteen percent of
the patients (N = 25) were smoking at the time of
transplantation, 61.9% had hypertension, and the mean
Charlson Comorbidity Index was 3.92 (1.9) points.
Eighty-two patients (58.3%) were on dialysis prior to
the transplantation with a median duration of 7 (IQR
32) months. Nineteen percent of the transplantations
were deceased kidney transplantations, 81.3% were per-
formed with a living donor, and 18% were retransplan-
tations.
Frailty and postoperative complications
The mean GFI score for the entire population was 2.07
(1.6, range 0–8). Twenty-three patients were consid-
ered frail with a GFI score ≥4 (Fig. 1).
The mean CCI for all kidney transplant recipients
was 18 (15.6, range 0–91.1), whereas the mean score
for patients who were classified as frail (GFI ≥4) was
30.1(17.2, range 8.7–91.1) (N = 23), compared to a
mean score of 15.5 (14.2, range 0–62.9) for the
Table 2. Baseline characteristics.
Parameters
Number, mean  SD*,
or median with IQR†
Percentage
or range




Age (years) Mean 51.81  SD 14.5 18–81 years
ASA score‡ Median 3 IQR 0 1–4
Comorbidity (Charlson)§ Median 3 IQR 3 2–11
Hypertension 86 61.9%
BMI¶ recipient Median 25.5 IQR 5.4 18.0–42.5
Smoking 25 18%
Pretransplant dialysis 81 58.3%
Pre-emptive 58 41.7%





Pre-emptive retransplantation 5 11.6%
*Standard deviation.
†Interquartile range.
‡American Society of Anesthesiologists score (classification system for assessing the
fitness of patients prior to surgery; range 1–5).
§Charlson Comorbidity Index (predicts 1-year mortality based on age and the
patients’ comorbidities; (0–10).
¶Body Mass Index (body mass (kg)/(height (m)2)).
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nonfrail (GFI <4) patients (N = 116) (Fig. 2). Delayed
graft function (DGF) occurred in 8% (N = 11) of all
patients, with 36% (N = 4) of these being retransplanta-
tions. DGF occurred in 55% (N = 6/11) of the non-
heart-beating transplantations, in 20% (N = 3/15) of
the heart-beating transplantations, and in 1.8% (N = 2/
113) of the total living donations. 7.8% (N = 9/116) of
the nonfrail and 8.7% (N = 2/23) of the frail patients
had a delayed graft function.
The number of major complications was low, with
most complications being graded as grade one or two
within the Clavien–Dindo classification (i.e., candida
infections, supraventricular tachycardia, metabolic acido-
sis, and clostridium infections). All grade two to five
complications were broken down into the following
events: minor cardiovascular (CV) events [Atrial fibrilla-
tion (AF) de novo, arrhythmia not treated with medica-
tion or cardioversion, stable angina pectoris complaints],
major CV events (myocardial infarction, arrhythmia
treated with medication or cardioversion, ICU admission
because of CV events), pulmonary events, diabetic events
(impaired glucose regulation with symptoms and intensi-
fied treatment), surgical interventions (redo surgery,
abscess/wound drainages, applying vacuum-assisted clo-
sure devices, and endoscopic procedures), and death of a
patient (Table 3). There were no statistically significant
differences in these events between frail and nonfrail
patients. The mean 30-day postsurgery eGFR for all
patients was 54.2 ml/min*173 m2 with no significant
difference between the frail and nonfrail patients.
Thirty-day outcome
Univariate analyses for variables potentially associated
with the CCI score are shown in Table 4. For the
adjusted analysis, 8 (GFI, age, Charlson Comorbidity
Index, smoking, dialysis, duration of dialysis, type of
transplantation, retransplantation) of the initial 12 vari-
ables (GFI, sex, age, ASA, Charlson Comorbidity Index,
hypertension, BMI, smoking, dialysis, duration of dialy-
sis, type of transplantation, retransplantation) were
added to the multivariable model (Table 5) and back-
ward selection was applied.
The adjusted analysis showed that frailty (b = 13.3;
95% CI: 5.72–20.89; P = 0.0007) and type of transplan-
tation (b = 4.9; 95% CI: 0.7–9.2, P = 0.02) were statisti-
cally significant factors associated with an increase in
CCI (Table 5). Being frail and type of transplantation
resulted in an average of 13.3-point and 4.9-point
increase in the CCI score, respectively (Fig. 2).
Discussion
This study shows that frailty, the Charlson Comorbidity
Indicator, and the transplantation type proved to be
independent risks factors for the occurrence of postop-
erative complications after kidney transplantation. Out
of these three, frailty has been shown to be the most
influential factor. Identifying frail patients, especially
when receiving a deceased donor kidney, can be an
important step in managing postoperative complica-
tions. In recent years, frailty has gained an increased
interest as a predictive tool for the outcome after (ma-
jor) surgical procedures by accurately and easily mea-
suring the patient’s physiologic reserves and the ability
Figure 1 Distribution of GFI score at admission. GFI, Groningen
Frailty Indicator, Orange bars = GFI ≥4 (frail).
Figure 2 Relation between frailty and CCI. Relation between
Groningen Frailty Indicator Score (GFI; ≥4 considered as frail) and
Comprehensive Complication Score (CCI) within 30-day postsurgery.
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Table 3. Distribution of major
complications between frail and
nonfrail patients.
GFI <4 GFI* ≥4 P-value
Minor CV events 6% (N = 7) 4.3% (N = 1) 0.36
Major CV events 0.8% (N = 1) 4.3% (N = 1) 0.42
Pulmonary events 1.7% (N = 2) 4.3% (N = 1) 0.75
Diabetic events* 4.3% (N = 5) 13% (N = 3) 0.42
Surgical interventions† 9.5% (N = 11) 8.7% (N = 2) 0.34
Death of a patient 0% (N = 0) 0% (N = 0) NA
CV, cardiovascular; GFI, Groningen Frailty Indicator.
*Impaired glucose regulation with symptoms.
†Redo surgery, abscess/wound drainages, applying vacuum-assisted closure devices
and endoscopic procedures.
Table 4. Univariate analysis with
the 30-day Comprehensive
Complication Index as dependent
variable.
Variable B 95% CI P-value
GFI ≥4 14.54 7.90–21.18 <0.01
Sex 0.54 4.90 to 5.98 0.84
Age 0.19 0.01–0.37 0.04
ASA score* 4.54 1.98 to 11.05 0.17
Charlson Comorbidity Index† 2.36 0.95–3.78 <0.01
Hypertension 0.79 4.77 to 6.35 0.78
BMI‡ 0.18 0.76 to 0.41 0.55
Smoking 4.67 2.02 to 11.37 0.17
Preemptive 3.83 9.33 to 1.67 0.17
Duration dialysis 0.07 0.05 to 0.19 0.24
Kidney transplantation type 11.22 4.72–17.73 <0.01
Retransplantation 4.06 2.80 to 10.92 0.24
*American Society of Anesthesiologists score (classification system for assessing the
fitness of patients prior to surgery; range 1–5).
†Charlson Comorbidity Index (predicts 1-year mortality based on age and the
patients’ comorbidities.
‡Body Mass Index (body mass (kg)/(height (m)2)).
Table 5. Multivariable model on
the association of frailty with the
30-day Comprehensive
Complication Index.
Variable B 95% CI P-value
GFI ≥4 13.31 5.72–20.89 <0.01
Age 0.001 0.28 to 0.28 0.99
Charlson Comorbidity Index† 1.19 0.94 to 3.32 0.27
Smoking 4.41 2.63 to 11.45 0.22
Preemptive 1.59 5.86 to 9.04 0.67
Duration dialysis 0.08 0.25 to 0.09 0.35
Type of transplantation 4.94 0.72–9.16 0.02
Retransplantation 3.56 4.27 to 11.38 0.37
†Charlson Comorbidity Index (predicts 1-year mortality based on age and the
patients’ comorbidities.
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to cope with surgical stressors. Previous research has
shown the predictive power of frailty in various medical
contexts but an investigation of the prognostic capaci-
ties of frailty for complications after kidney transplanta-
tion, measured by a simple questionnaire, is still
difficult to be efficiently implemented. Frailty is a com-
plex status consisting of several components and
domains. Usually, these domains are separately tested in
which the sum of these tests determine the degree of
frailty. This approach may be time-consuming, affecting
the clinical applicability and usability. The GFI is cer-
tainly not the holy grail when it comes to measuring
frailty but covers most areas and appears to be strongly
correlated to postoperative outcomes. This, combined
with the user’s convenience, enables the clinician to
determine frailty relatively simple and be informed on
the postoperative risks. Regarding kidney transplanta-
tions, there is a 61% higher risk (P = 0.002) of early
hospital readmission (≥1 hospitalization within 30 days
after post-transplantation hospital discharge) for frail
patients compared to nonfrail recipients [15] as well as
a more than twofold increased risk of mortality [16].
Also, there appears to be a relationship between delayed
graft function in kidney transplant recipients and frailty,
which could be related to the chronic inflammatory
processes seen in frail patients [17]. Additionally, frailty
status has been shown to support the mortality predic-
tion for patients with advanced kidney disease and the
shared decision-making about commencing dialysis in
these patients [18].
The phenotype of the frail patient seems related to
the increased inflammatory state [3] and a decreased
immune function [19] including elevated cortisol levels
[20], which is a likely explanation for a delayed recovery
and increased risk for postoperative complications.
Because of a continuing shortage of donors, there is a
growing pressure on the waiting list for suitable organs.
Additionally, the demand for kidney transplantations is
constantly growing due to the demographic develop-
ment of our society. More elderly people are therefore
considered more prone to chronic and end-stage kidney
disease requiring transplantation. Having a tool that
helps to quickly and efficiently assess the postoperative
risks after kidney transplantation is essential for improv-
ing the optimal treatment of the patient as well as opti-
mizing time management and therefore effectiveness
and hospital capacities.
Frail patients can be supported by preventive mea-
sures in order to reduce the occurrence and severity of
the expected complications, thereby improving the med-
ical outcome. These measures can include for example
preoperative conditioning, consisting of exercise inter-
vention programs that improve functional outcomes,
also known as the concept of prehabilitation [21,22].
Optimization of nutrition prior to surgery, combined
with early mobilization after surgery [23], might also
help to reduce the risks of frail patients, which are often
anemic, malnourished, and hypoalbuminemic [24].
Implementation of such measures, based on the result
of frailty assessment as part of the preoperative process
and a more individualized and adjusted healthcare sys-
tem, could significantly help to improve the short-term
outcome after kidney transplantation and increase its
efficiency, by for example optimizing the expected
length of stay. Interestingly, in our cohort, frailty did
not lead to significantly more CV or pulmonary compli-
cations, redo surgery, or death. The increase in CCI-
score was mainly determined by Clavien–Dindo grade 1
complications, which consist of any deviation from the
normal postoperative course without the need for phar-
macological treatment or surgical, endoscopic and radi-
ological interventions, except for antiemetics,
antipyretics, analgesics, diuretics drugs, electrolyte sup-
plementation, blood transfusion, total parental nutri-
tion, and physiotherapy. Most likely this is caused by
the high number of living donor recipients and it is
expected that this number will be higher among frail
deceased donor recipients.
With the previously demonstrated effect of frailty on
mortality and early hospital readmission after kidney
transplantation [15,16] and our results of the increased
surgical complication risk, frailty should play an impor-
tant role in patient evaluation and preparation.
Our study has several limitations that need to be
addressed. First, only the 30-day outcome has been
analyzed, whereas a long-term observation might be
more conclusive. Second, quality of life of the patient
has not been taken into consideration, even though it
might have more impact on the patient than surgical
complications alone. Third, with the GFI, we made a
reliable estimate of the degree of frailty but cannot rule
out that we have missed certain components. However,
we believe that the usability outweighs the risk of over-
or underestimating frailty. Also, even though the speci-
ficity is relatively low, the profit that can be achieved
is very high. Fourth and final, although we prospec-
tively and consecutively included our patients, we
missed a number of (complete) GFI forms, of mostly
deceased transplantation recipients. This appears to be
due to the variable, unplannable and often nightly
times on which patients were admitted to the hospital
and the reduced staff capacity prior to surgery. Because
72 Transplant International 2019; 32: 66–74
ª 2018 The Authors. Transplant International published by John Wiley & Sons Ltd on behalf of Steunstichting ESOT
Schopmeyer et al.
of the risk of bias, we decided to refrain from deter-
mining the GFI after surgery at the time this was
noticed. Unfortunately, this has also led to a skewed
distribution between living and deceased kidney trans-
plantations. In general, living donor recipients are in a
better state of health with less need for dialysis. This
will in all likelihood have led to an underestimation of
frailty in our population and we expect an even greater
effect of frailty in the deceased kidney transplant pro-
gram. Our team is continuing to work on this project
by increasing the number of patients and future studies
will have focus on long-term outcome and an even
more detailed approach on frailty (bioimpedance,
nutritional status, grip strength) in kidney transplant
recipients.
Conclusion
Frailty is an independent predictor for the 30-day
postsurgery outcome after kidney transplantation, caus-
ing a 13.4-point Comprehensive Complication Index
increase even after adjusting for important confounders
and risk factors. Frailty should be considered an
important prognostic preoperative tool for kidney
transplantations and be part of patient evaluation and
preparation.
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